Company intelligence

B-Secur

Committed to reducing CVD-related preventable deaths through advanced biosensing technology.

Software Development
Belfast, GB
11–50 employees
2 public signals

About B-Secur

B-Secur is committed to reducing preventable deaths from cardiovascular disease (CVD) through advanced, clinically validated biosensing algorithms that enable early diagnosis and proactive health management. With decades of academic R&D in ECG analysis and front-end design and origins in biometric security, our expertise in noise artifact detection and reduction delivers FDA-cleared clinical-grade ECG solutions for next-generation wearable health devices and platforms. HeartKey® is a suite of powerful ECG algorithms and analytics that enhances signal clarity, reduces signal noise, and delivers FDA-cleared health data with actionable wellness insights: *Cloud- and chip-based solutions *Clinically validated ECG algorithms and analytics *Platform agnostic solutions *High accuracy on dry electrodes in real time *Proprietary AI machine-learning and filter techniques We partner with world-leading technology companies to enable innovation, speed to market and operational efficiencies for next-generation medical and consumer devices and platforms.

Verified activity

Signals from B-Secur

2 published signals

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.